Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

VEC.L News

UK SMALLCAP ROUNDUP: Egdon Resources Up On Production Boost
14 Jun 2010

UK SMALLCAP ROUNDUP: Egdon Resources Up On Production Boost

Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps EGD...

TechMARK movers: ProStrakan director buys
11 Jun 2010

TechMARK movers: ProStrakan director buys

ProStrakan non-executive director Dr Frank Fildes has acquired 40,000 shares in the pharma company at 70.11p each. The £28,000 investment takes his st...

UK MARKET TALK ROUNDUP: BROKERS COMMENTS
8 Jun 2010

UK MARKET TALK ROUNDUP: BROKERS COMMENTS

Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, markets.eu@dowjones.com Contact us in London. +44-20-7842-9464 Markett...

MARKET TALK: KBC Peel Hunt Upgrades Vectura To Buy
8 Jun 2010

MARKET TALK: KBC Peel Hunt Upgrades Vectura To Buy

1012 GMT [Dow Jones] KBC Peel Hunt upgrades Vectura Group (VEC.LN) to buy from hold following the drug maker's decision to seek partners to help it de...

TechMARK movers: Axis-Shield slumps by one-fifth
10 May 2010

TechMARK movers: Axis-Shield slumps by one-fifth

Diagnostics firm Axis-Shield lost more than one-fifth of its value after it admitted that sales so far this year are much lower than expected. Axis...

Vectura narrows losses, $7.5m milestone payment
10 May 2010

Vectura narrows losses, $7.5m milestone payment

Respiratory inhaler firm Vectura says it has narrowed full-year losses and received a $7.5m milestone payment from Novartis after its Swiss partner st...

TechMARK movers: Sandoz buy concerns Vectura investors
20 Apr 2010

TechMARK movers: Sandoz buy concerns Vectura investors

Drugs developer Vectura continues to fall on the news that Sandoz, the generics business of Novartis, has acquired rival respiratory drugs firm Oriel ...

TechMARK movers: Share buying in Antisoma
9 Apr 2010

TechMARK movers: Share buying in Antisoma

Shares in cancer drug developer Antisoma have had little to cheer about in recent weeks. They plunged at the end of March following news that Novartis...